Loading...
01/10 05:58
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal strong financial performance, strategic expansions, and positive hiring trends, particularly in Texas. The company is executing well on acquisitions and capital allocation, with expectations for margin improvement in 2026. Despite some uncertainties, the overall sentiment is positive due to strategic growth initiatives and stable financial health. Given the market cap, the stock is likely to see a moderate positive reaction.
Total Revenue $362.3 million, an increase of 25% compared to $289.8 million for Q3 2024. The growth was driven by acquisitions and organic growth.
Adjusted Earnings Per Share (EPS) $1.56, an increase of 20% compared to $1.30 for Q3 2024. This was due to revenue growth and operational improvements.
Adjusted EBITDA $45.1 million, an increase of 31.6% compared to $34.3 million for Q3 2024. This was attributed to revenue growth and cost management.
Operating Cash Flow Over $50 million for Q3 2025. Strong cash flow performance supported by consistent collections.
Cash on Hand Approximately $102 million as of September 30, 2025. This provides financial flexibility for acquisitions.
Bank Debt $154 million as of September 30, 2025, with net leverage under 1x adjusted EBITDA. This allows for strategic acquisitions.
Personal Care Same-Store Revenue Growth 6.6% compared to Q3 2024, driven by a 2.4% increase in same-store hours and improved authorized hours served.
Hospice Same-Store Revenue Growth 19% compared to Q3 2024, driven by a 9.5% increase in average daily census and 6.5% increase in same-store admissions.
Home Health Same-Store Revenue Decreased by 2.8% compared to Q3 2024. Admissions have stabilized year-over-year.
Gross Margin Percentage 32.2%, an increase from 31.8% in Q3 2024. Sequentially decreased from 32.6% in Q2 2025 due to an extra holiday.
Adjusted G&A Expenses 19.8% of revenue, a decrease from 20% in Q3 2024 and Q2 2025, reflecting cost management.
Adjusted EBITDA Margin 12.5%, an increase from 11.8% in Q3 2024, driven by revenue growth and operational efficiencies.
Net Cash Flow from Operations $51.3 million for Q3 2025 and $92.7 million year-to-date, supported by consistent cash collections.
Revenue Growth: Total revenue for Q3 2025 was $362.3 million, a 25% increase compared to $289.8 million in Q3 2024.
Adjusted Earnings Per Share: Adjusted EPS increased by 20% to $1.56 in Q3 2025 compared to $1.30 in Q3 2024.
Adjusted EBITDA: Adjusted EBITDA rose by 31.6% to $45.1 million in Q3 2025 compared to $34.3 million in Q3 2024.
Acquisition of Del Cielo Home Care Services: Acquired personal care operations in South Texas, adding $12.7 million in annualized revenue and increasing market density in Texas.
Rate Increases in Texas and Illinois: Texas implemented a 9.9% rate increase effective October 1, 2025, adding $17.7 million in annualized revenue. Illinois announced a 3.9% rate increase effective January 1, 2026, adding $17.5 million in annualized revenue.
Hiring Performance: Achieved 113 hires per business day in Q3 2025, a 6.6% increase over Q2 2025. Starts per business day improved to 86.
Same-Store Revenue Growth: Personal care same-store revenue grew by 6.6%, and hospice same-store revenue grew by 19% in Q3 2025 compared to Q3 2024.
Expansion of Market Presence: Continued focus on acquisitions to enhance geographic coverage and density, including the acquisition of Helping Hands Home Care Services and Del Cielo Home Care Services.
Legislative Advocacy: Ongoing efforts to secure rate increases and favorable reimbursement policies in various states.
Medicare payment reductions: The proposed 6.4% aggregate reduction in Medicare payments to home health agencies in 2026 could negatively impact revenue and profitability for the home health segment.
Regulatory approval delays: The Illinois rate increase for personal care services is subject to the standard federal approval process, which could delay its implementation and associated revenue benefits.
Urban market hiring challenges: Clinical hiring remains stable overall but faces challenges in certain urban markets, potentially impacting service delivery in those areas.
Medicaid redeterminations: Medicaid redeterminations in Illinois have impacted personal care admissions, although the situation is improving.
Seasonal cost pressures: Seasonal factors, such as an extra holiday in the quarter, have slightly reduced gross margins.
Home health segment underperformance: The home health segment experienced a 2.8% decrease in same-store revenue compared to the previous year, indicating underperformance in this area.
Acquisition risks: The company continues to pursue acquisitions, which carry inherent risks such as integration challenges and financial strain.
Rate Increases in Texas and Illinois: The Texas rate increase for personal care services was effective October 1, 2025, and the Illinois rate increase will be effective January 1, 2026, subject to federal approval. These increases are expected to positively impact revenue and margins.
Hospice Reimbursement Rate Update: The fiscal year 2026 hospice wage index and payment rate update will result in a 3.1% increase in hospice rates, effective October 1, 2025, based on the current geographic and acuity mix.
Proposed Home Health Payment Rule for 2026: CMS has proposed a 6.4% aggregate reduction in Medicare payments to home health agencies for 2026 compared to 2025. Advocacy efforts are ongoing to mitigate this reduction, with final rates expected to be published soon.
Personal Care Segment Growth: Volume growth is expected to contribute more significantly to personal care same-store revenue growth in the future, with admissions in Illinois projected to exceed discharges by the end of Q4 2025.
Acquisition Strategy: The company plans to continue focusing on acquisitions to enhance geographic coverage and density, particularly in Texas and other strategic markets. Smaller clinical transactions and personal care service acquisitions will be prioritized.
Home-Based Care Growth Opportunity: The company anticipates continued growth opportunities in home-based care due to heightened awareness of its value and cost-effectiveness.
The selected topic was not discussed during the call.
The earnings call summary and Q&A reveal strong financial performance, strategic expansions, and positive hiring trends, particularly in Texas. The company is executing well on acquisitions and capital allocation, with expectations for margin improvement in 2026. Despite some uncertainties, the overall sentiment is positive due to strategic growth initiatives and stable financial health. Given the market cap, the stock is likely to see a moderate positive reaction.
The earnings call highlights strong financial performance with a 20.3% revenue increase and a 25.1% rise in adjusted EBITDA. The company is actively expanding through acquisitions and has a solid cash position. The guidance remains optimistic with stable EBITDA margins and growth in personal care and home health segments. Despite some uncertainties in the Q&A, like the caregiver app's impact, overall sentiment is positive, supported by strategic acquisitions and potential favorable rate movements in key states. Given the company's small-cap status, these factors suggest a positive stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
